Steve Pedrini

270 Joondalup Drive
Joondalup, WA 6027, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Divergent recovery trajectories after mild traumatic brain injury are characterized by distinct acute profiles of neurofilament light, 4R-tau, and white matter diffusivity.

Divergent recovery trajectories after mild traumatic brain injury are characterized by distinct acute profiles of neurofilament light, 4R-tau, and white matter diffusivity.

Journal: Journal of neurology

Published: May 17, 2026

USP14 inhibitor IU1 alleviates amyloid-β mediated toxicity in Alzheimer's disease cell and worm models.

USP14 inhibitor IU1 alleviates amyloid-β mediated toxicity in Alzheimer's disease cell and worm models.

Journal: Journal of Alzheimer's disease : JAD

Published: March 13, 2026

Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease.

Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: December 09, 2025

Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.

Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.

Journal: Journal of neurochemistry

Published: November 09, 2025

The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression.

The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression.

Journal: Molecular neurobiology

Published: May 12, 2025

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

Journal: Journal of neurology

Published: September 21, 2024

The moderating effect of diet on the relationship between depressive symptoms and Alzheimer's disease-related blood-based biomarkers.

The moderating effect of diet on the relationship between depressive symptoms and Alzheimer's disease-related blood-based biomarkers.

Journal: Neurobiology of aging

Published: August 06, 2024

Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.

Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.

Journal: Journal of neurochemistry

Published: July 26, 2024

The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults.

The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults.

Journal: GeroScience

Published: January 11, 2024

Fluid biomarkers in cerebral amyloid angiopathy.

Fluid biomarkers in cerebral amyloid angiopathy.

Journal: Frontiers in neuroscience

Published: November 30, 2023

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.

Journal: npj aging

Published: February 22, 2023

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: February 13, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026